A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography–Tandem Quadrupole Mass Spectrometry (LC–QQQ-MS)
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Novel psychoactive substances (NPS) continue to represent a threat to public health and safety. The number of new drugs in the latest emergent synthetic opioid class—the 2-benzylbenzimidazole analogs—also called the nitazenes—has begun to dominate the current new synthetic opioid (NSO) subclass of NPS. We describe a liquid chromatography–tandem quadrupole mass spectrometry method for the quantification of nine analogs and/or metabolites of drugs in this series: isotonitazene, metonitazene, protonitazene, etonitazene, clonitazene, flunitazene, N-desethyl isotonitazene, 5-amino isotonitazene and 4ʹ-hydroxy nitazene in human whole blood, urine, and tissue. Samples were prepared for analysis using a basic liquid–liquid extraction. Chromatographic separation was achieved using a C-18 analytical column. Multiple reaction monitoring mode was used for detection. The calibration range for the analytes was 0.5–50 ng/mL (except for 5-amino isotonitazene, which was 1.0–50 ng/mL). The limit of detection was 0.1 ng/mL, and the limit of quantitation was 0.5 ng/mL. The method had no carryover or interferences. Ionization enhancement was observed but did not affect quantitation. All analytes passed the method validation assessment. Authentic human samples suspected of containing NSOs were obtained from a medical examiner and coroner offices, as well as partnering forensic toxicology laboratories. Isotonitazene was confirmed in 92 blood samples, and its metabolites were confirmed across various matrices. Metonitazene (n = 35), flunitazene (n = 5), protonitazene (n = 3), etodesnitazene (n = 2) and butonitazene (n = 1) were also detected in cases. These newly emerging 2-benzylbenzimidazole analogs were commonly found in combination with NPS benzodiazepines and opioids (e.g., flualprazolam, fentanyl). Nitazene analogs are potent esoteric drugs that may not be identified during routine toxicological screening, and specialized assays based on sensitive instrumentation are needed to accurately characterize these NSOs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, the expected high in vivo potency of certain piperidine benzimidazolones stresses the need for highly sensitive analytical instrumentation for their detection (Walton et al., 2021).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Walton et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since then, additional analogs including metonitazene, protonitazene, etonitazene, and etodesnitazene have been reported in forensic, toxicology, and drug checking settings [14].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The structural differences in these analogs matter clinically because small chemical modifications alter potency, metabolism, and the ability of routine toxicology screenings to detect exposure [14].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“of nitazene tools confirm that while immunoassays may function as a screening method, they will not replace confirmatory mass spectrometry at the moment because of the inconsistent sensitivity and specificity [14].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mattson, C. L., Tanz, L. J., Quinn, K., Kariisa, M., Patel, P., & Davis, N. L. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7006a4 · Cited by 1,063 · cited 6×
“In the USA, isotonitazene was reported in many states across the East and Midwest, including Illinois, Indiana, Ohio and Wisconsin (13, 14).”
BackgroundInfluentialVandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146 · cited 3×
“by examining in vivo metabolism following the ingestion of isotonitazene based on the presence of the parent drug (Figure 1) (10).”
BackgroundSelf-citationBlanckaert, P., Cannaert, A., Van Uytfanghe, K., Hulpia, F., Deconinck, E., Van Calenbergh, S., & Stove, C. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2738 · Cited by 116
Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. J. (1957) · Cellular and Molecular Life Sciences · doi:10.1007/bf02161116 · Cited by 103 · cited 1×
“Isotonitazene is a structural analog of etonitazene, a potential therapeutic agent first synthesized in 1957 as an analgesic; however, etonitazene was never clinically approved for use in humans (6, 7).”
BackgroundKrotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91 · cited 1×
“, butonitazene, etodesnitazene) were screened by liquid chromatography quadrupole time-of-flight mass spectrometry (LC–QTOF-MS) and subsequently quantitated using standard addition with analysis by LC–QQQ-MS, after verification of the standard addition process for each drug (24).”
MethodSelf-citationKrotulski, A. J., Papsun, D. M., Noble, C., Kacinko, S. L., & Logan, B. K. (2021) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14623 · Cited by 47 · cited 8×
“In the USA, isotonitazene was reported in many states across the East and Midwest, including Illinois, Indiana, Ohio and Wisconsin (13, 14).”
BackgroundSelf-citationFlualprazolam Blood Concentrations in 197 Forensic Investigation Cases
Papsun, D. M., Krotulski, A. J., Homan, J., Temporal, K. D. H., & Logan, B. K. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa070 · Cited by 46 · cited 1×
“forensic toxicology casework screened via mass spectrometry per month) (11, 12).”
BackgroundSelf-citationEmerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study
Shover, C. L., Falasinnu, T. O., Freedman, R. B., & Humphreys, K. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000775 · Cited by 37 · cited 2×
“The authors of this manuscript would like to acknowledge the following individuals for their contributions to the project: Donna Papsun and Kyle Miller from NMS Labs; Eric Lavins and Szabi Sofalvi from Cuyahoga CountyMedical Examiner’s Office; Amy Miles and Aaron Zane from the Wisconsin State Lab of Hygiene; and Judit…”
Background
Research works printed but not linked: 3
- Krotulski, 2020, Isotonitazene quantitation and metabolite discovery in authentic forensic casework, Journal of Analytical Toxicology, 44, 521, 10.1093/jat/bkaa016 · DOI · Paper page
- The Woods at Parkside, 2021, Isotonitazene Found in Growing Ohio Overdose Deaths
- Controlled Substances - Alphabetical Order Alphabetical Order
Cited by
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Pergolizzi Jr, J., Raffa, R., LeQuang, J. A. K., Breve, F., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.40736 · Cited by 81
“There is scant information on the pharmacokinetics and pharmacodynamics of the street nitazenes [14].”
Schumann, J. L., Syrjanen, R., Alford, K., Mashetty, S., Castle, J. W., Rotella, J., Maplesden, J., & Greene, S. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac062 · Cited by 61
De Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
“OH nitazene is a universal metabolite of all nitazenes with alkoxy chain modifications only (Taoussi et al. 2024; Kanamori et al. 2024; Walton et al. 2021).”
BackgroundSelf-citationNon-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55
Mu-Opioid Receptor Selective Superagonists Produce Prolonged Respiratory Depression
Malcolm, N. J., Palkovic, B., Sprague, D. J., Calkins, M. M., Lanham, J. K., Halberstadt, A. L., Stucke, A. G., & McCorvy, J. D. (2023) · iScience · doi:10.1016/j.isci.2023.107121 · Cited by 53
“The extent to which nitazenes undergoN-deethylation after in vivo administration is not clear, but in a published analysis of samples collected during toxicology casework,N-desethyl isotonitazene and isotonitazene were detected in blood samples at similar concentrations.(55) If the N-deethylation of nitazenes does occ…”
Background
Metadata
- Authors
- Walton, S. E., Krotulski, A. J., & Logan, B. K.
- Affiliations
- Thomas Jefferson University (US)
- Corresponding author
- Krotulski, Alex J
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-18
- Volume
- 46
- Issue
- 3
- Pages
- 221-231
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- PMC
- PMC8935987
- OpenAlex
- W3212915836
- Cited by
- 92
- References
- 9
- Citations by year
- 2026: 19 · 2025: 38 · 2024: 17 · 2023: 11 · 2022: 7
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Analytical Toxicology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- The Medicine Forum (submittedVersion, cc-by-nc)
- Funders
- National Institute of Justice (2020-DQ-BX-0007)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
- Social Sciences › Law › Cybercrime and Law Enforcement Studies
- Keywords
- nitazenes, synthetic opioids, new psychoactive substances, isotonitazene, etonitazene, forensic toxicology, LC-MS/MS method development, multiple reaction monitoring, liquid-liquid extraction
- MeSH terms
- Analgesics, Opioid, Benzimidazoles, Chromatography, Liquid, Humans, Forensic Toxicology, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography–Tandem Quadrupole Mass Spectrometry (LC–QQQ-MS). https://app.cochat.ai/papers/10.1093/jat/bkab117
- The paper
- Walton, S. E., Krotulski, A. J., & Logan, B. K. (2022). A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography–Tandem Quadrupole Mass Spectrometry (LC–QQQ-MS). Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkab117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.